HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ECHA Advises Registrants, Downstream Users Post-May REACH Deadline

This article was originally published in The Rose Sheet

Executive Summary

More than 9,000 registration dossiers were submitted to the European Chemicals Agency under the May 31 REACH deadline, representing 2,923 substances in total, the agency reports. Registrants should double-check to ensure they made the necessary confidentiality claims, as “most of the information” in dossiers will be published on ECHA’s website.

You may also be interested in...



ECHA Launches REACH 2018 Web Portal For Low-Tonnage Registrants

New pages on the European Chemicals Agency’s website are targeted to firms facing registration and reporting requirements under the REACH program’s May 31, 2018 deadline. Addressing seven “phases” of registration, the REACH 2018 portal provides information and tips to manufacturers and importers of chemicals in volumes less than 100 tons, who should begin compiling their dossiers now, the agency says.

First REACH Deadline Accumulates Data On "Most Problematic" Chemicals

The European Chemicals Agency has greater insight into the safety of the "most problematic" substances following the Nov. 30 deadline under the EU's Registration, Evaluation, Authorization and Restriction of Chemicals law.

FDA’s Cannabidiol Crackdown: What Do Warning Letters Say About CBD In Cosmetics?

Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.

UsernamePublicRestriction

Register

RS018568

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel